Skip to main content

Table 3 Comparison of retinal and choroidal thickness measurements using EDI-OCT in patients with SCD with and without retinopathy

From: Retinal and choroidal thickness in pediatric patients with sickle cell disease: a cross-sectional cohort study

 

SCD with retinopathy

Mean µm ± standard deviation (median)

SCD without retinopathy

Mean µm ± standard deviation (median)

p value

Retinal thickness

 Central

253.00 ± 23.39 (256.00)

258.15 ± 19.40 (256.00)

0.665

 Superior parafovea

347.48 ± 30.20 (346.00)

343.16 ± 14.37 (344.00)

0.423

 Nasal parafovea

348.52 ± 22.39 (346.00)

344.06 ± 13.79 (343.00)

0.298

 Inferior parafovea

345.26 ± 19.94 (344.00)

341.94 ± 11.33 (341.50)

0.313

 Temporal parafovea

332.11 ± 18.60 (331.00)

330.17 ± 14.66 (329.00)

0.688

 Superior perifovea

323.26 ± 13.12 (320.00)

314.84 ± 12.49 (314.50)

0.029*

 Nasal perifovea

330.11 ± 18.58 (329.00)

323.94 ± 12.55 (325.00)

0.636

 Inferior perifovea

313.36 ± 17.04 (313.00)

307.26 ± 17.00 (303.50)

0.356

 Temporal perifovea

297.44 ± 11.97 (294.00)

291.06 ± 10.04 (289.00)

0.058

Choroidal thickness

 Fovea

237.50 ± 17.86 (235.50)

242.46 ± 22.85 (240.00)

0.391

 Temporal parafovea

230.45 ± 17.18 (230.00)

231.41 ± 22.93 (229.00)

0.854

 Nasal parafovea

224.40 ± 16.03 (225.00)

224.59 ± 19.09 (222.00)

0.979

 Temporal perifovea

228.70 ± 34.87 (214.00)

215.77 ± 27.40 (210.00)

0.108

 Nasal perifovea

202.80 ± 16.62 (199.00)

202.13 ± 18.18 (200.00)

0.953

  1. *p < 0.05 is significant